Long-Acting Injectable (LAI) Technology
Creative Biolabs is a leader in the field of vaccine, and we embrace the entire system of technologies and services in the vaccine industry, from upstream design to downstream production and peripheral formulation development and so on. Long-acting injectable (LAI) technology is a delivery method that delivers long-lasting and stable release of the drug, and a number of experiments have proven its excellence.
Background
Treatment adherence is a major challenge for schizophrenia due to the complexity of the disease. The long-acting injection drug delivery system has the characteristics of releasing drugs for several days or even several months after a single local injection, and has been a formulation technology of concern to life science researchers and pharmaceutical companies around the world. Long-acting preparations can alleviate patients’ pain and discomfort due to medication. The use of long-acting preparations also increases the selectivity of the drug for patients, providing a very meaningful solution for some drugs that are effective but are limited in application due to instability, toxic side effects, and other limiting factors. At the same time, for pharmaceutical companies, the development of long-acting preparations can bring a large market and a very large profit.
Long-Acting Injectable (LAI) Technology
Long-acting injection preparations are kind of drug formulations that form a depot when injected into the body. The drug is released slowly over ≥1 week (up to six months). Long-acting injection preparations generally include liposomes, microspheres, emulsions, and nanomedicines. Although there are not many products, they make up a market of 18 billion dollars in the world, and the economic benefits even exceed the new molecular entities. Creative Biolabs' unique LAI technology enables long-term and stable delivery of small molecule drugs and biopharmaceuticals. This technology can be precisely matched with the active pharmaceutical ingredients and the human physiological environment to achieve the desired effect.
Highlight Features of LAI Technology
- Strong drug loading capacity
- Stable and controlled release of drugs
- Compatible with proteins, peptides and small molecule drugs to ensure their activity
- Low viscosity
- Suitable for subcutaneous, intramuscular, or other localized injection
- Scalable and low-cost production
Creative Biolabs' long-acting injectable (LAI) technology is well suited to meet the long-term release requirements of drugs, and it is more desirable for patients with schizophrenia who have difficulties to adhere to medication. Moreover, this technology can be applied to different modes of administration, and the production cost is low. If you are interested in this technology, please call us!
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
